nLc4
| Product Name | nLc4 |
|---|---|
| Alternate Names | - Carbohydrates, Carbohydrates of - |
| CAT No. | CS-O-50698 |
| CAS No. | Not Available |
| Category | Carbohydrates |
| Stock | Enquire |
| Mol. Wt. | 707.63 g/mol |
| Mol. For. | C26H45NO21 |
| Hazardous | This is not a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | - |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Get an Instant Quote
Related Compounds
GD3Cer d20:1/8:0 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | Lewis Y (Le Y) | GlcNAcproN3 | GD2Cer d18:1/20:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | FucGM1sph d20:1 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbSphingolipids) | GD2 | LewisaCer d20:1/24:1-Biotin (Galb1,3(Fuca1,4)GlcNAcb1,3Galb1,4GlcbCeramide-Biotin) | GT2Cer d18:1/24:1 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GM1bCer d18:1/18:0 (Neu5Aca2,3Galb1,3GalNAcb1,4Galb1,4GlcbCeramide) | GM2Cer d18:1/18:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GD1asph d18:1 ((Neu5Aca2,3)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1 | Gb5 | GT1cCer d20:1/24:1 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GM3Cer d20:1/12:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | GT3Cer d20:1/8:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | SiaNAl | nLc4Cer d18:1/18:0-Biotin (Galb1,4GlcNAcb1,3Galb1,4GlcbCeramide-Biotin) | GD1bCer d18:1/18:0-Biotin (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide-Biotin) | L-Rhamnulose | GD2Cer d20:1/20:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GD3Cer d18:1/16:0 (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | FucGM1Cer d18:1/8:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GloboH | GQ3sph d20:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbSphingolipids) | GalNAcb1, 3Gal | Neu5Gca2, 3Galb1, 4GlcNAc | Zymosan | Epiprogoitrin potassium salt | GD2Cer d18:1/18:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | Blood type trisaccharide H Type II | H-Antigen-Cer d18:1/18:0-Biotin ((Fuca1,2)Galb1,4GlcbCeramide-Biotin) | GT3sph d20:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbSphingolipids) | Lewis A (Lea ) pentasaccharide | GloboHCer d18:1/18:0-Biotin ((Fuca1,2)Galb1,3GalNAcb1,3Gala1,4Galb1,4GlcbCeramide-Biotin) | GM2Cer d18:1/20:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | Sialyl-iGB5Cer d18:1/18:0-Biotin ((Neu5Aca2,3)Galb1,3GalNAcb1,3Gala1,3Galb1,4GlcbCeramide-Biotin) | Glucoerucin potassium salt | D-galactosyl-α-1,1' N-palmitoyl-D-erythro-sphingosine | GM1aCer d18:1/8:0 (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM1aCer d18:1/18:0-Biotin (Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide-Biotin) | GD1bCer d18:1/12:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GD2Cer d18:1/12:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | Galc d18:1/20:0（GalaCeramide） | Neu5Aca2,3（HSO4 -6-)Galb1,4GlcNAc | FucGM1Cer d18:1/12:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GM3Cer d20:1/16:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | GD3Cer d18:1/18:0-Biotin (Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide-Biotin) | Lc3 | GT1cCer d18:1/16:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GM2Cer d18:1/24:1 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GlcNAcb1, 3Galb1, 4GlcNAc | GT2Cer d20:1/18:0 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GT2Cer d20:1/24:1 (GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GD1bCer d18:1/8:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GM3Cer d20:1/18:0 (Neu5Aca2,3Galb1,4GlcbCeramide) | GM2Cer d18:1/12:0 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GQ3Cer d20:1/24:1 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | Blood type trisaccharide A | GT1cCer d18:1/18:0 (Galb1,3GalNAcb1,4(Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3)Galb1,4GlcbCeramide) | GM1bCer d18:1/18:0-Biotin ((Neu5Aca2,3)Galb1,3GalNAcb1,4Galb1,4GlcbCeramide-Biotin) | FucGM1sph d18:1 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbSphingolipids) | FucGM1Cer d20:1/8:0 ((Fuca1,2)Galb1,3GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | GT3Cer d20:1/20:0 (Neu5Aca2,8Neu5Aca2,8Neu5Aca2,3Galb1,4GlcbCeramide) | GM1bCer d18:1/24:1 (Neu5Aca2,3Galb1,3GalNAcb1,4Galb1,4GlcbCeramide) | Gluconasturtiin potassium salt | iGloboHCer d18:1/18:0-Biotin ((Fuca1,2)Galb1,3GalNAcb1,3Gala1,3Galb1,4GlcbCeramide-Biotin) | GM2Cer d18:1/24:1 (GalNAcb1,4(Neu5Aca2,3)Galb1,4GlcbCeramide) | Carrageenan | iGB4Cer d18:1/18:0-Biotin (GalNAcb1,3Gala1,3Galb1,4GlcbCeramide-Biotin) | Fucose 1-phosphate |